NCT03673033

Brief Summary

The study was designed as a prospective cohort study. The effects of hot and cold ischemic times during live donor liver transplantation on postoperative 1-3 and 6 month follow up biliary complications will be investigated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
99

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 10, 2018

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

September 13, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 17, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2019

Completed
4 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 3, 2019

Completed
Last Updated

October 3, 2019

Status Verified

September 1, 2018

Enrollment Period

1.4 years

First QC Date

September 13, 2018

Last Update Submit

October 1, 2019

Conditions

Keywords

Transplantation, Hepatic, Cirrhosis, Bile duct

Outcome Measures

Primary Outcomes (1)

  • development of biliary complication in the first month after liver transplantation

    biliary complication at the first month after transplantation and whether this complication is interfered with or not will be evaluated.

    1 month

Secondary Outcomes (2)

  • development of biliary complication in the three months after liver transplantation

    3 months

  • development of biliary complication in the six month after liver transplantation

    6 months

Interventions

calculation of hot and cold ischemia durations from donor artery cut-off time in liver transplantation

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult patients with live donor liver transplant for any reason

You may qualify if:

  • Live donor liver transplantation Emergency Live donor liver transplantation Multiple or single bile duct anastomosis in liver transplantation

You may not qualify if:

  • Hepaticojejunostomy Cadaveric liver transplantation Pediatric liver transplantation Cmv infection presence Hepatic arterial thrombus Porta thrombus Acute rejection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cihan Gokler

Malatya, 44090, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Fibrosis

Interventions

Liver Transplantation

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Tissue TransplantationCell- and Tissue-Based TherapyBiological TherapyTherapeuticsDigestive System Surgical ProceduresSurgical Procedures, OperativeOrgan TransplantationTransplantation

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal invastigator

Study Record Dates

First Submitted

September 13, 2018

First Posted

September 17, 2018

Study Start

March 10, 2018

Primary Completion

July 30, 2019

Study Completion

August 3, 2019

Last Updated

October 3, 2019

Record last verified: 2018-09

Data Sharing

IPD Sharing
Will share

de-identified individual participant data for all primary, secondary and tertiary outcome measures will be made available

Shared Documents
STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
Time Frame
data will be available within 6 months of study completion
Access Criteria
data access request will be reviewed by an external independent review panel.

Locations